Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

Cited by (1,006)

Items 501–600 of 1,006

  1. Re‐examining ethnic differences in concerns, knowledge, and beliefs about Alzheimer's disease: results from a national sample
    Liat Ayalon · 2013 · International Journal of Geriatric Psychiatry
  2. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease
    Nadia El Kadmiri, Ilham Slassi, Bouchra El Moutawakil, Sellama Nadifi, Artavazd Tadevosyan, Ahmed Hachem, Abdelaziz Soukri · 2014 · Pathologie Biologie
  3. Challenges in the association of human single nucleotide polymorphism mentions with unique database identifiers
    Philippe E Thomas, Roman Klinger, Laura Ines Furlong, Martin Hofmann‐Apitius, Christoph M. Friedrich · 2011 · BMC Bioinformatics
  4. Risk and protective factors for sporadic Alzheimer's disease.
    Zuzana Stožická, Norbert Žilka, M Novák · 2007 · PubMed
  5. Quantifying Selective Reporting and the Proteus Phenomenon for Multiple Datasets with Similar Bias
    Thomas Pfeiffer, Lars Bertram, John P. A. Ioannidis · 2011 · PLoS ONE
  6. The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease
    Yulei Deng, Lihua Liu, Ying Wang, Huidong Tang, Ru‐Jing Ren, Wei Lin Xu, Jianfang Ma, Liling Wang, Jun-Peng Zhuang, Gang Wang et al. · 2012 · Human Genetics
  7. Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures
    Налетова Ирина Николаевна, Elena V. Schmalhausen, A. J. Kharitonov, Aleksey Katrukha, Luciano Saso, Antonio Caprioli, Vladimir I. Muronetz · 2008 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  8. Discovery and replication of dopamine-related gene effects on caudate volume in young and elderly populations (N=1198) using genome-wide search
    Jason L. Stein, Derrek P. Hibar, Sarah K. Madsen, M. Khamis, Katie Louise McMahon, Greig Ian de Zubicaray, Narelle K. Hansell, Grant W. Montgomery, Nicholas G. Martin, Margaret J. Wright et al. · 2011 · Molecular Psychiatry
  9. Large-scale De Novo Prediction of Physical Protein-Protein Association
    Antigoni L Elefsinioti, Ömer Sinan Saraç, Anna Hegele, Conrad Plake, Nina C. Hubner, Ina Poser, Mihail Sarov, Anthony A. Hyman, Matthias Mann, Michael Schroeder et al. · 2011 · Molecular & Cellular Proteomics
  10. Genotator: A disease-agnostic tool for genetic annotation of disease
    Dennis Paul Wall, Rimma Perotte, Mark Y. Tong, Jae-Yoon Jung, Vincent A. Fusaro, Todd F. DeLuca, Peter J. Tonellato · 2010 · BMC Medical Genomics
  11. Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
    Shanker Swaminathan, Li Shen, Shannon L. Risacher, Karmen K. Yoder, John D. West, Sungeun Kim, Kwangsik T. Nho, Tatiana Foroud, Mark H. Inlow, Steven G. Potkin et al. · 2011 · Brain Imaging and Behavior
  12. Clinical phenotype, atrophy, and small vessel disease in APOE ε2 carriers with Alzheimer disease
    Colin Groot, Carole H. Sudre, Frederik Barkhof, Charlotte Elisabeth Teunissen, Bart N.M. van Berckel, Sang Won Seo, Sebastien Ourselin A, Philip Scheltens, M. Jorge Cardoso, Wiesje M. van der Flier et al. · 2018 · Neurology
  13. Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi‐Ethnic (FLAME) cohort
    Octavio A. Santos, Otto Pedraza, John Alexander Lucas, Ranjan Duara, Maria T. Greig‐Custo, Fadi S. Hanna Al‐Shaikh, Amanda M. Liesinger, Kevin F. Bieniek, Kelly M. Hinkle, Elizabeth R. Lesser et al. · 2019 · Alzheimer s & Dementia
  14. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades
    Christopher Carter · 2007 · Neurochemistry International
  15. The APOE ε4 exerts differential effects on familial and other subtypes of Alzheimer's disease
    Longfei Jia, Hui Xu, Shuoqi Chen, Xiu Wang, Jianwei Yang, Min Gong, Cuibai Wei, Yi Tang, Qiumin Qu, Lan Chu et al. · 2020 · Alzheimer s & Dementia
  16. Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function
    Katherine A. B. Kellett, Jonathan Williams, Emma R. L. C. Vardy, A. David Smith, Nigel M. Hooper · 2011 · Europe PMC (PubMed Central)
  17. A critical role of RBM8a in proliferation and differentiation of embryonic neural progenitors
    Donghua Zou, Colleen McSweeney, Aswathy Sebastian, Derrick James Reynolds, Fengping Dong, Yijing Zhou, Dazhi Deng, Yonggang Wang, Long Liu, Jun Zhu et al. · 2015 · Neural Development
  18. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease
    John S. K. Kauwe, Sarah E. Bertelsen, K. Mayo, Carlos Cruchaga, Richard Abraham, Paul Hollingworth, Denise H. Harold, Michael John Owen, Julie H. Williams, Simon Lovestone et al. · 2009 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  19. Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease
    Onofre Combarros, Cornelia M. van Duijn, Naomi Hammond, Olivia Belbin, Alejandro Arias Vásquez, Mario Cortina‐Borja, Michael G. Lehmann, Yurii S. Aulchenko, Maaike Schuur, Heike Kölsch et al. · 2009 · Journal of Neuroinflammation
  20. Identification of genetic heterogeneity of Alzheimer's disease across age
    Min‐Tzu Lo, Karolina Kauppi, Chun-Chieh Fan, Nilotpal Sanyal, Emilie T. Reas, V. S. Sundar, Wen‐Chung Lee, Rahul S. Desikan, Linda K. McEvoy, Chi‐Hua Chen · 2019 · Neurobiology of Aging
  21. CD2-associated protein (CD2AP) overexpression accelerates amyloid precursor protein (APP) transfer from early endosomes to the lysosomal degradation pathway
    Kotaro Furusawa, Toshiyuki Takasugi, Yung‐Wen Chiu, Yukiko Hori, Taisuke Tomita, Mitsunori Fukuda, Shin‐ichi Hisanaga · 2019 · Journal of Biological Chemistry
  22. Endophenotypes in normal brain morphology and Alzheimer's disease: a review
    Christiane Reitz, Richard P Mayeux · 2009 · Neuroscience
  23. Genome-wide linkage analysis of 723 affected relative pairs with late-onset Alzheimer's disease
    Marian L. Hamshere, Peter Holmans, Dimitrios Avramopoulos, Susan Spear Bassett, Deborah Blacker, Lars Bertram, Howard W. Wiener, Nan Rochberg, Rudolph E. Tanzi, Amanda Myers et al. · 2007 · Human Molecular Genetics
  24. A Reduced Astrocyte Response to β-Amyloid Plaques in the Ageing Brain Associates with Cognitive Impairment
    Mathur, Ryan, Ince, Paul G., Minett, Thais, Garwood, Claire J., Shaw, Pamela J., Matthews, Fiona E., Brayne, Carol, Simpson, Julie E., Wharton, Stephen B., on behalf of the MRC Cognitive Function and Ageing Neuropathology Study Group · 2015 · PLOS ONE
  25. Genes and Longevity of Lifespan
    May Nasser Bin-Jumah, Muhammad Shahid Nadeem, Sadaf Jamal Gilani, Fahad Ahmed Al-Abbasi, Inam Ullah, Sami Ibrahim Alzarea, Mohammed M. Ghoneim, Sultan Alshehri, Aziz Ud-Din, Bibi Nazia Murtaza et al. · 2022 · International Journal of Molecular Sciences
  26. Epigenetic dysregulation in Alzheimer’s disease peripheral immunity
    Abhirami Ramakrishnan, Natalie Piehl, Brooke Simonton, Milan N. Parikh, Ziyang Zhang, Victoria Teregulova, Lynn van Olst, David Gate · 2024 · Neuron
  27. Age, Gender, and Cancer but Not Neurodegenerative and Cardiovascular Diseases Strongly Modulate Systemic Effect of the Apolipoprotein E4 Allele on Lifespan
    Kulminski, Alexander M., Arbeev, Konstantin G., Culminskaya, Irina, Arbeeva, Liubov, Ukraintseva, Svetlana V., Stallard, Eric, Christensen, Kaare, Schupf, Nicole, Province, Michael A., Yashin, Anatoli I. · 2014 · PLoS Genetics
  28. Modernizing the systematic review process to inform comparative effectiveness: tools and methods
    Byron Wallace, Issa J Dahabreh, Christopher H. Schmid, Joseph Lau, Thomas A Trikalinos · 2013 · Journal of Comparative Effectiveness Research
  29. Computable cause‐and‐effect models of healthy and Alzheimer's disease states and their mechanistic differential analysis
    Alpha Tom Kodamullil, Erfan Younesi, Mufassra Naz, Shweta Bagewadi, Martin Hofmann‐Apitius · 2015 · Alzheimer s & Dementia
  30. Brain insulin resistance deteriorates cognition by altering the topological features of brain networks
    Fan Su, Hao Shu, Qing Ye, Zan Wang, Chunming Xie, Baoyu Yuan, Zhijun Zhang, Feng Bai · 2016 · NeuroImage Clinical
  31. Brain-Wide Genome-Wide Association Study for Alzheimer's Disease via Joint Projection Learning and Sparse Regression Model
    Tao Zhou, Kim‐Han Thung, Mingxia Liu, Dinggang G. Shen · 2018 · IEEE Transactions on Biomedical Engineering
  32. The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
    Marija Čuljak, Matea Nikolac Perković, Suzana Uzun, Dubravka Švob Štrac, Gordana Nedić Erjavec, Mirjana Babić Leko, Goran Šimić, Lucija Tudor, Marcela Konjevod, Oliver Kozumplik et al. · 2020 · Current Alzheimer Research
  33. The Alzheimer's disease risk factor CD2AP maintains blood–brain barrier integrity
    J. Nicholas Cochran, Travis Rush, Susan C. Buckingham, Erik D. Roberson · 2015 · Human Molecular Genetics
  34. GAPscreener: An automatic tool for screening human genetic association literature in PubMed using the support vector machine technique
    Wei Yu, Mindy Clyne, Siobhan M. Dolan, Ajay Yesupriya, Anja Wulf, Tiebin Liu, Muin J. Khoury, MARTA L. GWINN · 2008 · BMC Bioinformatics
  35. A Knowledge-Based Weighting Framework to Boost the Power of Genome-Wide Association Studies
    Miaoxin Li, Pak Chung Sham, Stacey Shawn Cherny, You‐Qiang Song · 2010 · PLoS ONE
  36. Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
    Sophie Laurent, Mohammad Reza Ejtehadi, Meisam Rezaei, Patrick G. Kehoe, Morteza Mahmoudi · 2012 · RSC Advances
  37. In Vivo Imaging of Venous Side Cerebral Small-Vessel Disease in Older Adults: An MRI Method at 7T
    C. Elizabeth Shaaban, Howard Jay Aizenstein, Dana Rae Jorgensen, Rebecca L. MacCloud, Nicole A. Meckes, Kirk I. Erickson, Nancy W. Glynn, Joseph Mettenburg, Jack M. Guralnik, Anne B. Newman et al. · 2017 · American Journal of Neuroradiology
  38. The effect of APOE genotype on Alzheimer's disease risk is influenced by sex and docosahexaenoic acid status
    Matthew G. Pontifex, David Vauzour, Anne Marie Minihane · 2018 · Neurobiology of Aging
  39. Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II
    Maria Aliseychik, Т. В. Андреева, Evgeny Ivanovich Rogaev · 2018 · Biochemistry (Moscow)
  40. Machine learning based multimodal neuroimaging genomics dementia score for predicting future conversion to alzheimer’s disease
    Mirabnahrazam, Ghazal, the Alzheimer’s Disease Neuroimaging Initiative, Ma, Da, Lee, Sieun, Popuri, Karteek, Lee, Hyunwoo, Cao, Jiguo, Wang, Lei, Galvin, James E., Beg, Mirza Faisal · 2022 · Journal of Alzheimer's Disease
  41. Familial idiopathic normal pressure hydrocephalus
    Joel Huovinen, Sami Kastinen, Simo Komulainen, Minna Oinas, Cecilia Avellan, Janek Frantzén, Jaakko Rinne, Antti Ronkainen, Mikko Tapio Kauppinen, Kimmo Lönnrot et al. · 2016 · Journal of the Neurological Sciences
  42. The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders
    Bruce X. W. Wong, James A. Duce · 2014 · Frontiers in Pharmacology
  43. Biomarkers in the Diagnosis and Prognosis of Alzheimer’s Disease
    Cole Schaffer, Nakia Sarad, Ashton DeCrumpe, Disha Goswami, Sara Herrmann, Jose Morales, Parth Patel, Jim Osborne · 2014 · SLAS TECHNOLOGY
  44. Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease
    Davide Seripa, Francesco Panza, Marilisa Franceschi, Grazia D’Onofrio, Vincenzo Solfrizzi, Bruno Dallapiccola, Alberto Pilotto · 2009 · Ageing Research Reviews
  45. Sex specific molecular networks and key drivers of Alzheimer’s disease
    Guo, Lei, Cao, Jiqing, Hou, Jianwei, Li, Yonghe, Huang, Min, Zhu, Li, Zhang, Larry, Lee, Yeji, Duarte, Mariana Lemos, Zhou, Xianxiao et al. · 2023 · Molecular Neurodegeneration
  46. Implication of common and disease specific variants in CLU, CR1, and PICALM
    Raffaele Ferrari, Jorge H. Moreno, Abu Minhajuddin, Sid E. O’Bryant, Joan Reisch, Robert C. Barber, Parastoo Momeni · 2012 · Neurobiology of Aging
  47. Autophagy-lysosomal pathway impairment and cathepsin dysregulation in Alzheimer’s disease
    Alquiandra Stefani Ferreira Mançano, Juliana Guanaes Pina, Bruna Rojas Froes, Juliana Mozer Sciani · 2024 · Frontiers in Molecular Biosciences
  48. BioAge: Toward a multi-determined, mechanistic account of cognitive aging
    Correne A. DeCarlo, Holly Anna Tuokko, Dorothy Williams, Roger A. Dixon, Stuart W. S. MacDonald · 2014 · Ageing Research Reviews
  49. A domain level interaction network of amyloid precursor protein and Aβ of Alzheimer's disease
    Victoria M. Perreau, Sandra E. Orchard, Paul Anthony Adlard, Shayne A. Bellingham, Roberto Cappai, Giuseppe D. Ciccotosto, Tiffany Cowie, Peter John Crouch, James A. Duce, Genevieve M. Evin et al. · 2010 · PROTEOMICS - CLINICAL APPLICATIONS
  50. Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model
    Xiaorui Cheng, Xiuliang Cui, Yue Zheng, Guirong Zhang, Peng Li, Huang Huang, Yueying Zhao, Xiaochen Bo, Shengqi Wang, Wenxia Zhou et al. · 2013 · Frontiers in Aging Neuroscience
  51. Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease
    Henna Martiskainen, Annakaisa Haapasalo, Kaisa M. A. Kurkinen, Jussi Pihlajamäki, Hilkka S. Soininen, Mikko O. Hiltunen · 2013 · Expert Opinion on Therapeutic Targets
  52. Caspase-8, association with Alzheimer’s Disease and functional analysis of rare variants
    Jan Rehker, Johanna Rodhe, Ryan Nesbitt, Evan A. Boyle, Beth Martin, Jenny Lord, Ilker Karaca, Adam Christian Naj, Frank Jessen, Seppo Helisalmi et al. · 2017 · PLoS ONE
  53. Migration and cognitive function: a conceptual framework for Global Health Research
    Hanzhang Xu, Allison Amend Vorderstrasse, Eleanor Schildwachter McConnell, Matthew E. Dupre, Truls Østbye, Bei Wu · 2018 · Global Health Research and Policy
  54. The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
    Julio César García Casallas, Rosa‐Helena Bustos · 2018 · Brain Sciences
  55. Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease
    Belin, Andrea Carmine, Björk, Behnosh F., Westerlund, Marie, Galter, Dagmar, Sydow, Olof, Lind, Charlotta, Pernold, Karin, Rosvall, Lina, Håkansson, Anna, Winblad, Bengt et al. · 2007 · Neuroscience Letters
  56. Evaluation of the Potential Excess of Statistically Significant Findings in Published Genetic Association Studies: Application to Alzheimer's Disease
    Fotini K. Kavvoura, Matthew B. McQueen, Muin J. Khoury, Rudolph E. Tanzi, Lars Bertram, John P. A. Ioannidis · 2008 · American Journal of Epidemiology
  57. Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
    Mirjana Babić Leko, Dubravka Švob Štrac, Dorotea Mück‐Šeler, Nela Pivac, Gabrijela Stanić, Patrick R. Hof, Goran Šimić · 2014 · Croatian Medical Journal
  58. Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
    Allison Ann Dilliott, Sali M.K. Farhan, Mahdi Ghani, Christine Sato, Eric Liang, Ming Zhang, Adam D. McIntyre, Henian Cao, Lemuel Racacho, John F. Robinson et al. · 2018 · Journal of Visualized Experiments
  59. Discovering Alzheimer Genetic Biomarkers Using Bayesian Networks
    Fayroz F. Sherif, Nourhan Mohamed Zayed, Mahmoud A. Fakhr · 2015 · Advances in Bioinformatics
  60. No Association between CALHM1 and Alzheimer's Disease Risk
    Lars Bertram, Brit‐Maren M. Schjeide, Basavaraj V. Hooli, Kristina Mullin, Mikko O. Hiltunen, Hilkka S. Soininen, Martin Ingelsson, Lars Lannfelt, Deborah Blacker, Rudolph E. Tanzi · 2008 · Cell
  61. Association Between Interleukin-10 Polymorphisms and Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Danilo Di Bona, Claudia Rizzo, Giuseppe Bonaventura, Giuseppina Candore, Calogero Caruso · 2012 · Journal of Alzheimer s Disease
  62. Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes
    Jack‐Christophe Cossec, Catherine Marquer, Maı̈ Panchal, Adina Nicoleta Lazar, Charles J. Duyckaerts, Marie‐Claude Potier · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  63. Intermediate Phenotypes Identify Divergent Pathways to Alzheimer's Disease
    Joshua M Shulman, Lori Beth Chibnik, Cristin Aubin, Julie A. Schneider, David Bennett, Philip L. De Jager · 2010 · PLoS ONE
  64. From beta amyloid to altered proteostasis in Alzheimer’s disease
    Amalia Cecilia Bruni, Livia Bernardi, Carlo Gabelli · 2020 · Ageing Research Reviews
  65. Allele-specific polymerase chain reaction for the detection of Alzheimer’s disease-related single nucleotide polymorphisms
    Mohd Nazif Darawi, Chin Ai-Vyrn, Kalavathy Ramasamy, Philip Poi Jun Hua, Tan Maw Pin, Shahrul Bahyah Kamaruzzaman, Abu Bakar Abdul Majeed · 2013 · BMC Medical Genetics
  66. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease
    Sabrina Petralla, Maria Panayotova, Elisa Franchina, Gert Fricker, Elena Puris · 2024 · Pharmaceutics
  67. Amyloid‐β sequester proteins as blood‐based biomarkers of cognitive decline
    Kazuhiko Uchida, Shan Liu, Hideaki Suzuki, Yo Tabuse, Yoshinori Nishimura, Yoshihiro Hirokawa, Katsuyoshi Mizukami, Hiroyasu Akatsu, Kohji Meno, Takashi Asada · 2015 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  68. The Central Role of AMP-Kinase and Energy Homeostasis Impairment in Alzheimer’s Disease: A Multifactor Network Analysis
    Laura Caberlotto, Mario Lauria, Thanh-Phuong Nguyen, Marco Scotti · 2013 · PLoS ONE
  69. Function and Comorbidities of Apolipoprotein E in Alzheimer′s Disease
    Valérie Leduc, Dorothée Domenger, Louis De Beaumont, Daphnée Lalonde, Stéphanie Bélanger Jasmin, Judes Poirier · 2011 · International Journal of Alzheimer s Disease
  70. Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine
    Dorothy G. Flood, Gerard J. Marek, Michael J. Williams · 2011 · Biochemical Pharmacology
  71. Emerging role of Alzheimer's disease-associated ubiquilin-1 in protein aggregation
    Annakaisa Haapasalo, Jayashree Viswanathan, Lars Bertram, Hilkka S. Soininen, Rudolph E. Tanzi, Mikko O. Hiltunen · 2010 · Biochemical Society Transactions
  72. Structural and functional neural correlates of visuospatial information processing in normal aging and amnestic mild cognitive impairment
    Karolina Alichniewicz, Florian Brunner, Hans H. Klünemann, Mark W. Greenlee · 2012 · Neurobiology of Aging
  73. Isolation and characterization of the Drosophila ubiquilin ortholog dUbqln: in vivo interaction with early-onset Alzheimer disease genes
    A. Li, Zhongcong Xie, Yuanlin Dong, Kenneth Matthew McKay, Mary L. McKee, Rudolph E. Tanzi · 2007 · Human Molecular Genetics
  74. Genetic variation in BIN1 gene and Alzheimer's disease risk in Han Chinese individuals
    Meng‐Shan Tan, Jin‐Tai Yu, Teng Jiang, Xi‐Chen Zhu, Hua-Shi Guan, Lan Tan · 2014 · Neurobiology of Aging
  75. BIN1 gene rs744373 polymorphism contributes to Alzheimer's disease in East Asian population
    Guiyou Liu, Shuyan Zhang, Zhiyou Cai, You Li, Lili Cui, Guoda Ma, Yongshuai Jiang, Liangcai Zhang, Rennan Feng, Mingzhi Liao et al. · 2013 · Neuroscience Letters
  76. Plasma Clusterin and the CLU Gene rs11136000 Variant Are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients
    Rongrong Cai, Jing Han, Jie Lena Sun, Rong Huang, Sai Tian, Yanjue Shen, Xue Dong, Wenqing Xia, Shaohua Wang · 2016 · Frontiers in Aging Neuroscience
  77. DNA methylation in the APOE genomic region is associated with cognitive function in African Americans
    Jiaxuan Liu, Wei Zhao, Erin Bakshis Ware, Stephen T. Turner, Thomas H. Mosley, Jennifer A. Smith · 2018 · BMC Medical Genomics
  78. Genomic mechanisms in Alzheimer's disease
    Lars Bertram, Rudolph E. Tanzi · 2020 · Brain Pathology
  79. The fusiform gyrus exhibits an epigenetic signature for Alzheimer’s disease
    Dingailu Ma, Irfete Sh. Fetahu, Mei Wang, Rui Fang, Jiahui Li, Hang Liu, Tobin Gramyk, Isabella J. Iwanicki, Sophie Gu, Winnie Xu et al. · 2020 · Clinical Epigenetics
  80. Etiology and Pathophysiology of Frontotemporal Dementia, Parkinson Disease and Alzheimer Disease: Lessons from Genetic Studies
    Christian W. Wider, Zbigniew K. Wszołek · 2008 · Neurodegenerative Diseases
  81. Endothelin-Converting Enzymes and Related Metalloproteases in Alzheimer's Disease
    Javier Pacheco‐Quinto, Aimee R. Herdt, Christopher B. Eckman, Elizabeth A. Eckman · 2012 · Journal of Alzheimer s Disease
  82. Genetic Study of Neurexin and Neuroligin Genes in Alzheimer's Disease
    Martinez-Mir, Amalia, Alzheimer's Disease Neuroimaging Initiative, González-Pérez, Antonio, Gayán, Javier, Antúnez, Carmen, Marín, Juan, Boada, Mercé, Lopez-Arrieta, Jesús María, Fernández, Evaristo, Ramírez-Lorca, Reposo et al. · 2013 · Journal of Alzheimer's Disease
  83. AlzBase: An Integrative Database for Gene Dysregulation in Alzheimer’s Disease
    Bai, Zhouxian, Han, Guangchun, Xie, Bin, Wang, Jiajia, Song, Fuhai, Peng, Xing, Lei, Hongxing · 2016 · Molecular Neurobiology
  84. Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in A β and TAU proteostasis
    Sullivan, Sarah E, Liao, Meichen, Smith, Robert V, White, Charles, Lagomarsino, Valentina N, Xu, Jishu, Taga, Mariko, Bennett, David A, De Jager, Philip L, Young-Pearse, Tracy L · 2019 · Human Molecular Genetics
  85. Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
    Castrillo, Juan I., Oliver, Stephen G. · 2016 · Methods in Molecular Biology
  86. Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
    Zeba Firdaus, Xiaogang Li · 2024 · International Journal of Molecular Sciences
  87. Memory Resilience to Alzheimer’s Genetic Risk: Sex Effects in Predictor Profiles
    Kirstie L. McDermott, G. Peggy McFall, Shea J. Andrews, Kaarin Jane Anstey, Roger A. Dixon · 2016 · The Journals of Gerontology Series B
  88. Uncovering the impact of noncoding variants in neurodegenerative brain diseases
    Alexandros Frydas, Eline Wauters, Julie van der Zee, Christine Van Broeckhoven · 2021 · Trends in Genetics
  89. A Deep Generative–Discriminative Learning for Multimodal Representation in Imaging Genetics
    Wonjun Ko, Wonsik Jung, Eunjin Jeon, Heung‐Il Suk · 2022 · IEEE Transactions on Medical Imaging
  90. New light on an old CLU
    Lars Bertram, Rudolph E. Tanzi · 2010 · Nature Reviews Neurology
  91. AhR-mediated gene expression in the developing mouse telencephalon
    Julia M. Gohlke, Pat S. Stockton, Stella O. Sieber, Julie F. Foley, Christopher J. Portier · 2009 · Reproductive Toxicology
  92. Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
    Leonidas Chouliaras, Annerieke S. R. Sierksma, Günter Kenis, Jos Prickaerts, Marijke A.M. Lemmens, Ivona Brasnjevic, Eva L. van Donkelaar, Pilar Martínez‐Martínez, Mario H. Losen, Marc H. De Baets et al. · 2010 · International Journal of Alzheimer s Disease
  93. ACAT as a drug target for Alzheimer’s disease
    Huttunen, Henri J., Kovacs, Dora M. · 2008 · Neurodegenerative Diseases
  94. Distinguishing true from false positives in genomic studies: p values
    Linda Broer, Christina M. Lill, Maaike Schuur, Najaf Amin, Johannes T. Roehr, Lars Bertram, John P. A. Ioannidis, Cornelia M. van Duijn · 2013 · European Journal of Epidemiology
  95. HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease
    Fatima G. Ali-Rahmani, Cara‐Lynne Schengrund, James R. Connor · 2014 · Frontiers in Pharmacology
  96. Sortilin receptor 1 predicts longitudinal cognitive change
    Chandra A. Reynolds, Catalina Zavala, Margaret Gatz, Loryana L. Vie, Boo E. A. Johansson, Bo Malmberg, Erik Ingelsson, Jonathan A. Prince, Nancy L. Pedersen · 2013 · Neurobiology of Aging
  97. Genetic association of PICALM polymorphisms with Alzheimer's disease in Han Chinese
    Jin‐Tai Yu, Jinghui Song, Teng Ma, Wei Zhang, Nan‐Nan Yu, Shiying Xuan, Lan Tan · 2010 · Journal of the Neurological Sciences
  98. Network analysis of genes and their association with diseases
    Panagiota I. Kontou, Athanasia Pavlopoulou, Niki L. Dimou, Georgios A. Pavlopoulos, Pantelis G. Bagos · 2016 · Gene
  99. A diffusion model analysis of episodic recognition in preclinical individuals with a family history for Alzheimer’s disease: The adult children study.
    Andrew J. Aschenbrenner, David A. Balota, Brian Andrew Gordon, Roger Ratcliff, John C. Morris · 2015 · Neuropsychology
  100. Data mining of high density genomic variant data for prediction of Alzheimer's disease risk
    Natalia Briones, Valentin Dinu · 2012 · BMC Medical Genetics